✦ LIBER ✦

Molecular-cytogenetic characterization of head and neck cancer: Identification of novel prognostic factors and gene targets for therapy

✍ Scribed by Robert L. Ferris

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 78 KB
Volume: 29
Category: Article
ISSN: 1043-3074
DOI: 10.1002/hed.20591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cyclooxygenase-2: A novel molecular targ

Cyclooxygenase-2: A novel molecular target for the prevention and treatment of head and neck cancer

✍ Derrick T. Lin; Kotha Subbaramaiah; Jatin P. Shah; Andrew J. Dannenberg; Jay O. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

## Abstract Cyclooxygenase‐2 (COX‐2), an enzyme that catalyzes the synthesis of prostaglandins, is overexpressed in a variety of premalignant and malignant conditions, including oral leukoplakia and squamous cell carcinoma of the head and neck. Increased levels of COX‐2 may contribute to carcinogen

Alloantigen gene therapy for head and ne

Alloantigen gene therapy for head and neck cancer: Evaluation of animal models

✍ Lyon L. Gleich; Ya-Qin Li; Shunan Li; Jack L. Gluckman; Peter J. Stambrook 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

## Background: Human trials of alloantigen gene therapy, using the class i major histocompatibility complex (mhc) hla-b7, have demonstrated the potential efficacy of this treatment for head and neck cancer. its mechanism remains unclear. an immune-competent mouse model of mhc gene therapy to test f

Towards further understanding of prognos

Towards further understanding of prognostic factors for head and neck cancer patients: The example of hypopharyngeal cancer

✍ Stephen F. Hall; Patti A. Groome; Jonathan Irish; Brian O'Sullivan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 397 KB 👁 1 views

## Abstract ## Objectives: Knowledge of prognostic factors is essential for patient care and research. The objectives of this study were to demonstrate that prognostic factors and their impact can vary depending on study design and to examine the relationships between select prognostic factors. #

Altered metabolism in head and neck squa

Altered metabolism in head and neck squamous cell carcinoma: an opportunity for identification of novel biomarkers and drug targets

✍ Vlad C. Sandulache; Jeffrey N. Myers 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB 👁 1 views

## Abstract Tumor cells were first shown to exhibit a distinct metabolic phenotype over 80 years ago. Since then, it has become clear that multiple oncogenic events contribute to the development of a metabolic phenotype that supports rapid proliferation. Because this phenotype represents an essenti

Novel inactivating mutations of transfor

Novel inactivating mutations of transforming growth factor-β type I receptor gene in head-and-neck cancer metastases

✍ Taiping Chen; Wu Yan; Rebecca G. Wells; David L. Rimm; Jennifer McNiff; David Le 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 263 KB

Carcinoma cell lines are frequently refractory to transforming growth factor-beta (TGF beta)-mediated cell cycle arrest. Whether and how TGF beta signaling is disrupted in the majority of human tumors, however, remains unclear. To investigate whether TGF beta signaling might be disrupted by inactiva

Identification of a novel therapeutic ta

Identification of a novel therapeutic target for head and neck squamous cell carcinomas: A role for the neurotensin-neurotensin receptor 1 oncogenic signaling pathway

✍ Satoya Shimizu; Jun Tsukada; Takashi Sugimoto; Naoko Kikkawa; Keita Sasaki; Hide 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 321 KB 👁 1 views

## Abstract Distant metastasis is a major factor associated with poor prognosis in head and neck squamous cell carcinomas (HNSCC), but little is known of its molecular mechanisms. New markers that predict clinical outcome, in particular the ability of primary tumors to develop metastatic tumors, ar